Within a few years the reduced deuterium content preparation can be an anti-cancer drug
The AHYD Rákkutató és Gyógyszerfejlesztő Kft. (AHYD Cancer Research and Drug Development Ltd.) has taken another significant step towards the registration of the reduced deuterium content water (DDW) as an anticancer medicine.
The total value of the world-wide unique pharmaceutical investment is more than 250 million HUF. The investment was implemented with the help of the Primus Capital Kockázati Tőkealap-kezelő Zrt. (Primus Capital Venture Capital Fund Management Ltd.). The European Union also supported the project with 16.644 million HUF.
Related news
The World Science Forum starts in Budapest today
The World Science Forum (WSF) begins today in Budapest, with…
Read more >
Neglected national disease: every year we lose a small town’s worth of Hungarians to diabetes
In recent decades, diabetes has become a real public health…
Read more >
One drop closer to health: this is how daily fluid replacement can be exciting
Inadequate hydration can cause headaches, fatigue and concentration problems, yet…
Read more >Related news
A new chapter has opened in the history of Pizza Hut: The restaurant chain can be renewed based on the Hungarian model
On September 12, the ribbon was cut on Pizza Hut’s…
Read more >
150 million bottles, jars and aluminum cans have already been returned in Lidl stores
Lidl Hungary has reached a milestone in its new return…
Read more >
Style rethought – Hungaria sparkling wine has been renewed!
Hungaria, one of Hungary’s most popular bottle-fermented sparkling wine brands,…
Read more >
